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Background: Cervical lymphadenopathy could be seen in several pathologic processes. An accurate differentiation between these 
conditions is of utmost importance to select an appropriate therapy and assess the prognosis. Gray scale and Doppler are appropriate 
sonographic techniques for evaluating internal and external features of lymph nodes. Although, various criteria have been proposed to 
differentiate metastatic lymph nodes from benign ones, the most valuable and specific sonographic features are still under dispute.
Objectives: The present study was designed to determine valuable sonographic features for differentiating metastasis from benign nodes 
using gray scale and Doppler sonography.
Patients and Methods: A prospective diagnostic study was performed on 63 patients with head and neck squamous cell carcinoma 
(SCC) treated and referred to surgery clinic of Hazrat Rasoul Akram hospital from November 2010 to June 2012 with complaint of palpable 
cervical lymph node. All patients’ necks were scanned multidirectionally by gray-scale and Doppler techniques. After sonography, lymph 
nodes were biopsied and investigated to find out whether they were metastatic or reactive. Finally, demographic, sonographic and 
pathologic data were statistically analyzed by SPSS ver. 16 software using t-test, a nonparametric test and ROC analysis. Ninety five percent 
confidence interval was considered for all parameters.
Results: The study included 41 males and 22 females with a mean age of 57.56 ± 13.79 years. The number of metastatic lymph nodes was 47, 
while the remaining 16 were reactive. There were significant differences in length (P = 0.037), width (P = 0.001), resistance index (P < 0.001), 
pulsatility index (P < 0.001) and systolic velocity (P < 0.001) of metastatic and reactive lymph nodes. Cut points for resistive and pulsatility 
indexes and systolic velocity were calculated as 0.695, 1.35 and 16.5, respectively. The most valuable factor for defining a lymph node as 
metastatic was circulation pattern with accuracy, sensitivity and specificity of 94%, 85% and 93%, respectively.
Conclusion: Gray scale sonography in combination with Doppler sonography could be a trustworthy technique in differentiating 
metastatic lymph nodes from reactive ones. Although, circulation pattern had a higher diagnostic accuracy in the present study, 
combination of sonographic characteristics could be more beneficial in differentiating metastatic cervical nodes from reactive ones.
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1. Background
Approximately one third of body lymph nodes are 
placed in cervical region (1). Cervical lymphadenopathy 
could be seen in several pathologic processes such as 
lymphoma, tuberculosis and metastasis (2-4). Therefore, 
an accurate differentiation between these conditions is 
of utmost importance to select an appropriate therapy 
and assess the prognosis (5, 6). Five-year survival of pa-
tients with metastatic lymph node in one side of neck 
is 50% and presence of metastatic lymph nodes in both 
sides reduces the 5-year survival to 25% (7, 8).
Several imaging modalities such as computed to-
mography, magnetic resonance imaging and ultra-
sonography have been used for evaluation of cervical 
lymph nodes (9). Although some studies reported ul-
trasonography as the most sensitive technique, some 
others reported no statistical difference between these 
modalities in evaluation of cervical lymph nodes (7, 10). 
Moreover, ultrasonography is a fast and relatively in-
expensive modality and could determine small lymph 
nodes (< 55 mm) better than other techniques (10, 11). In 
addition, ultrasonography could assess both internal 
and external anatomy of cervical lymph nodes (11). Gray 
scale sonography is used for evaluation of number, 
size, shape and borders of lymph nodes (12-14). Pattern 
of intranodal vessels, blood flow velocity and vascular 
resistance are assessed by power Doppler sonography 
as well (15-18). Although, various criteria have been pro-
posed to differentiate metastatic lymph nodes from be-
nign ones, the most valuable and specific sonographic 
features are under dispute (19).
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2. Objectives
Because of mentioned factors, due to the importance 
of diagnosis of metastatic cervical lymph nodes diagno-
sis and appropriateness of sonography in evaluation of 
cervical lymph nodes, the present study was designed to 
determine valuable sonographic features for differentiat-
ing metastasis from benign nodes using gray scale and 
Doppler sonography.
3. Patients and Methods
This was a prospective diagnostic study on patients with 
head and neck squamous cell carcinoma (SCC) who had 
been treated. All patients were referred to surgery clinic 
of Hazrat Rasoul Akram hospital (a tertiary center) from 
November 2010 to June 2012 with complaint of palpable 
cervical lymph node. 
Based on the routine diagnosis and treatment protocol 
of Hazrat Rasoul Akram hospital surgery clinic for pa-
tients with head and neck SCC, after confirmation of pri-
mary diagnosis by tissue examination, an individualized 
treatment strategy is used for each patient as follows:
1- Surgery: whenever possible, oncology surgeons aimed 
to use minimally invasive surgical techniques to preserve 
patient’s function and appearance in the best way pos-
sible. 2- Radiation Therapy: in more extensive diseases, 
which restricted surgical excision resulting in incomplete 
resection or wide excisions causing severe morbidity. 3- 
Chemotherapy: a) Neoadjuvant chemotherapy (Chemo-
therapy only, given prior to radiation or surgery). Neoad-
juvant (or induction) chemotherapy was given to patients 
before radiation or surgery. The aim was to reduce the size 
of tumor and decrease distant metastasis, to improve the 
success of additional treatments. b) Concurrent chemo-
radiation (chemotherapy and radiation simultaneously). 
This treatment is considered the standard care in the fol-
lowing circumstances: for localized SCCs, for patients who 
have had their cancer completely removed by surgery but 
at a high risk of recurrence of cancer, for patients with lo-
cally advanced to larynx and certain patients with cancers 
of the oropharynx (e.g. tonsil, tongue). 4 -Neck Dissection: 
Whenever possible, the involved lymph nodes were re-
moved, sparing the sternocleidomastoid muscle, the spi-
nal accessory nerve and the internal jugular vein.
Treated patients were informed about routine follow-up 
visits and warned about alarm signs which should make 
them seek an out of schedule visit as soon as possible. The 
most insisted alarm sign was palpable neck mass, which 
probably represents neck adenopathy or recurrent tu-
mor. All patients with palpable neck mass diagnosed and 
confirmed by a surgeon, traditionally underwent surgi-
cal excisional biopsy of the largest palpated mass and 
the excised tissue sample was sent for pathological ex-
amination to rule out malignancy. During the study, new 
patients with palpable neck mass were referred for neck 
ultrasound examination according to Helsinki protocol 
and with a signed consent to delineate sonographic char-
acteristics of the mass found.
Referred patients’ necks were scanned multidirection-
ally by Gray-scale and duplex techniques. Investigation 
of all cervical lymph nodes was performed by a single 
trained resident of radiology (whom his experience was 
confirmed by professors of radiology) and reviewed by 
an assistant professor of radiology. Commercially avail-
able Esaote Mylabe™ seven with a 5-MHz curved probe 
and a 7.5 - 10 MHz linear probe was used for evaluating 
the largest lymph node in patients. Sonographic evalu-
ation was limited to the single largest palpated mass to 
avoid any additional confounding data and convenience 
of patient to avoid extra surgical biopsies. Data such as 
tumor length, width, appearance, circulation pattern 
and flow indices including resistive index (RI), pulsatility 
index (PI) and systolic velocity were gathered through so-
nographic studies. Studied variables were defined as fol-
lows; the maximal diameter was measured as the largest 
dimension for each node and minimal diameter was de-
fined as the largest diameter perpendicular to the maxi-
mal diameter in the axial plane.
The shape index was calculated as the ratio of the mini-
mal to maximal diameter. Consequently, lymph nodes 
with shape indexes below 0.5 were considered oval, 
whereas lymph nodes with shape indexes more than 0.5 
were defined as round (Figures 1 and 2). The resistance 
index defined as a measure of pulsatile blood flow that 
reflects the resistance to blood flow caused by microvas-
cular bed distal to the site of measurement.
The PI defined as the difference between the peak systol-
ic and minimum diastolic velocities divided by the mean 
velocity during the cardiac cycle. The peak systolic veloc-
ity or systolic velocity defined as the maximum speed of 
blood flow in the arterial segment studied. The vascu-
lar pattern was defined as configuration and pattern of 
vascular branching of feeding arteries specified to every 
other organ, which include central, peripheral (Figures 2 
and 3) and mixed patterns.
Figure 1. Round shape neck lymphadenopathy (arrows). A 70-year-old 
patient with treated hypopharyngeal SCC presented with submandibular 
neck mass, which proved to be benign reactive node in biopsy specimen, 
solid arrows indicate to the lymph nodes location and border to be distin-
guished from adjacent soft tissue 
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Figure 2. A 68-year-old patient with treated lip SCC by chemoradiation. 
Patient presented with middle neck mass, which biopsy specimen proved 
metastatic involvement due to SCC relapse. A and B, Round shape cervical 
lymphadenopathy (solid arrows) with peripheral pattern in color dop-
pler ultrasonography (thin arrows). A, Solid arrows indicate to the lymph 
nodes location and border to be distinguished from adjacent soft tissue. 
B, Thin arrows indicate to the peripherally located vasculatures as dis-
cussed in the text as a sign of metastatic lymph nodes. C, Histopathology 
image (100× magnification). 
The largest selected mass was easily palpated (mini-
mum length and width of largest palpated masses 
were 22 mm and 11 mm); but under sonography guide, 
it was marked by cutaneous color marker to avoid any 
unwanted missing during surgical excision. Then, exci-
sional biopsy of the marked mass was performed within 
seven days of sonography. All of the samples were in-
vestigated by a fourth year pathology resident and re-
viewed by an assistant professor of pathology to find 
out whether they were metastatic or reactive. Patholo-
gists were blinded to the results of sonography.
Finally, demographic, sonographic and pathologic data 
were statistically analyzed by SPSS ver. 16 software (SPSS 
Inc., Chicago, IL,  USA). T-test, Fisher exact test and Krus-
kal-Wallis test were used to evaluate the significance of 
parameters collected from the two investigated groups. A 
95% confidence interval (CI) was considered for all param-
eters. In addition, to distinguish different characteristics 
of lymph nodes, receiver operating characteristic (ROC) 
under the curve analysis was used to calculate the area 
under the curve (AUC) and sensitivity and specificity us-
ing discriminate thresholds (Figure 4).
4. Results
The study included 63 patients with head and neck SCC 
consisted of 41 males and 22 females. Mean age of pa-
tients was 57.56 ± 13.79 years ranging from 19 to 76 years. 
Mean age of patients with metastatic lymph nodes was 
59.36 years and mean age of patients with reactive lymph 
nodes was 52.25 years. There was no significant difference 
in gender of metastatic and reactive lymph node groups 
(P = 0.075). Moreover, there was no significant difference 
in patients’ age between two groups (P=0.721). 
Most patients had hypopharyngeal SCC (22%) followed 
by oropharyngeal (19%) and tongue (19%) cancers (Table 
1). According to pathology reports, the number of meta-
static lymph nodes was 47, while the remaining 16 were 
reactive. Thirty-three lymph nodes were round and the 
others were oval. Mean minimum and maximum diam-
eter of the lymph nodes were 21.11 mm and 34.03 mm, 
respectively. Circulation pattern of 41 lymph nodes was 
peripheral and the others had central (15 lymph nodes) 
or mixed (7 lymph nodes) circulation. Mean systolic 
velocity, RI and PI of lymph nodes were 19.51, 0.75 and 
1.67, respectively. There was a significant difference in 
some features of lymph nodes such as length, width, RI, 
PI and systolic velocity between metastatic and reactive 
lymph nodes (Table 2). Cut-off levels for different fea-
tures of lymph nodes were calculated using ROC analy-
sis to distinguish metastatic lymph nodes from reactive 
types as shown in Table 3.
Mean length diameter of metastatic lymph nodes was 
34.98 mm, while reactive lymph nodes had a 31.25 mm 
mean length diameter (P = 0.037) and mean width diam-
eter of these two groups were 22.62 mm versus 16.63 mm, 
respectively (P = 0.001). The cut-off level for length or maxi-
mal diameter of lymph nodes was 33.5 mm and this level 
for width or minimal diameter of lymph nodes was 18.5 
mm. Using these levels, the sensitivity, specificity, positive 
predictive value (PPV) and negative predictive value (NPV) 
of metastatic lymph nodes length were 59%, 68%, 84% and 
36%, respectively and these measures for width of meta-
static lymph nodes were 63%, 75%, 88% and 41%. The sensi-
tivity, specificity and accuracy for oval shaped metastatic 
lymph nodes were 63%, 68% and 64% (Table 4).
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Figure 3. A 71-year-old patient with laryngeal carcinoma treated with tumor resection and received adjuvant chemotherapy. Patient presented with lower 
neck mass, which biopsy specimen proved metastatic involvement due to SCC relapse. A, Cervical lymphadenopathy with peripheral vascular pattern 
in color doppler ultrasonography (arrows), thin arrows indicate to the peripherally located vasculatures as discussed in the text as a sign of metastatic 
lymph nodes. B, Histopathology image (400× magnification).
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Figure 4. Receiver operating characteristic (ROC) curves for differentiat-
ing metastatic and reactive lymph nodes in neck SCC
Table 1. Frequency of Different Types of SCC in Patients





Salivary gland 9 (14.3)
Lip 5 (7.9)
Table 2.  Comparison of Sonographic Features Between Meta-
static and Reactive Nodes a
Metastasis Reactive P Value
Length 34.98 ± 6.39 31.25 ± 4.82 0.037
Width 22.62 ± 7.43 16.63 ± 5.11 0.001
RI 0.79 ± 0.08 0.64 ± 0.08 < 0.001
PI 1.83 ± 0.52 1.18 ± 0.38 < 0.001
Systolic velocity 21.23 ± 5.14 14.44 ± 3.20 < 0.001
a Abbreviations: RI, resistive index; PI, pulsatility index
Mean systolic velocity, RI and PI of metastatic lymph 
nodes were 21.23, 0.79 and 1.83; while these measures were 
14.44, 0.64 and 1.18 in reactive lymph nodes (P < 0.001) (Ta-
ble 2). The cut-off level for RI, PI and systolic velocity were 
0.695, 1.35 and 16.5 using ROC analysis (Table 3). The AUC 
for characteristics of lymph nodes were 0.668 for length 
(95%CI: 0.517 - 0.818, P value = 0.047), 0.723 for width (95 % 
CI: 0.593 - 0.854, P value = 0.008) and 0.858 for systolic ve-
locity (95 % CI: 0.761 - 0.956, P value = < 0.001) (Figure 4). The 
diagnostic accuracy of these cut points is shown in Table 4.
According to the results, the most valuable feature for 
determining a lymph node as metastatic is circulation 
pattern and it has the highest accuracy (89%) among all 
lymph node features previously mentioned. Sensitivity, 
specificity, PPV and NPV of peripheral circulation pattern 
were 85%, 93%, 97% and 86%, respectively.
Exact regional distributions of detected lymph nodes 
were not specified for every patient. They were mostly dis-
tributed along the sternocleidomastoid instead of ster-
nocleidomastoid  muscles bilaterally, which corresponds 
to the zones II, III and IV. Zone I including submental and 
submandibular regions was less equally involved and 
there was no obvious involvement of zone V and supra-
clavicular nodes.
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Table 3.  Relationship Between Pathologic Results and Sonographic Parameters According to Calculated Cut Points a
Parameters Metastasis Reactive P Value
Appearance 0.05
Oval (L/W ratio < 0.5) 19 11
Round (L/W ratio > = 0.5) 28 5
Length 0.05
< 33.5 19 11
> = 33.5 28 5
Width 0.007
< 18.5 17 12
> = 18.5 30 4





> = 0.695 39 3
< 0.695 8 13
PI < 0.001
> = 1.35 39 5
< 1.35 8 11
Systolic Velocity < 0.001
> = 16.5 34 3
< 16.5 13 13
a Abbreviations: L/W, Length/Width; RI, resistive index; PI: pulsatility index
Table 4.  Comparison of Sensitivity, Specificity, PPV, NPV and Accuracy of Sonographic Features in Differentiating Metastatic Cervical 
Lymph Nodesa
Features Sensitivity Specificity PPV NPV Accuracy
Appearance 63 (49 - 78) 68 (43 - 94) 85 (93 - 97) 39 (20 - 58) 64 (42 - 83)
Length 59 (45 - 74) 68 (43 - 94) 84 (71 - 97) 36 (18 - 55) 61 (45 - 83)
Width 63 (49 - 78) 75 (51 - 98) 88 (76 - 99) 41 (22 - 60) 66 (51 - 84)
Circulation pattern 85 (74 - 95) 93 (80 - 100) 97 (92 - 100) 68 (47 - 89) 94 (77 - 98)
RI (> = 0.695) 83 (71 - 94) 81 (59 - 100) 92 (84 - 100) 61 (39 - 84) 82 (62 - 97)
PI (> = 1.35) 83 (71 - 94) 68 (43 - 94) 88 (78 - 98) 57 (33 - 82) 79 (52 - 93)
Systolic Velocity (> = 16.5) 72 (59 - 85) 81 (59 - 100) 91 (82 - 100) 50 (29 - 70) 74 (59 - 91)
a Abbreviations: PPV, positive predictive value; NPV, negative predictive value; RI, resistive index; PI, pulsatility index
5. Discussion
SCC tumors constitute most of head and neck malig-
nancies, which are roughly 5% of all carcinomas (20, 21). 
They are common cause of neck lymph nodes swelling 
and differentiating involved nodes from benign ones is 
still a real challenge (22). The efficacy of sonography for 
evaluation of neck lymph nodes has been shown by nu-
merous researchers (16, 23, 24). The role of both gray scale 
and color Doppler techniques for differentiating benign 
lymph nodes from metastatic ones by evaluating inter-
nal and external sonographic features is well established 
(25-28). However, no accurate criteria for differentiating 
metastatic lymph nodes from benign ones are yet deter-
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mined (24). In the present study, gray-scale sonographic 
features such as minimal and maximal diameters and 
shape as well as color Doppler features including circula-
tion pattern, RI, PI and systolic velocity were evaluated.
In the current study, a significant difference between 
vascular pattern of metastatic SCC and benign lymph 
nodes was found. The sensitivity of vascular pattern 
was 85% for differentiating metastatic SCC lymph nodes 
from benign ones in the present study. Most studies re-
ported sensitivity of this feature from 78% to 96% similar 
to the result of this study (5, 16, 17, 29-33). The specificity 
of this feature in the present study was 93%, which was in 
concordance with the results of some other studies re-
porting specificity from 91% to 100% (5, 29-32). In a study 
on cervical lymphadenopathy in patients with oral SCC, 
sensitivity and specificity of circulation pattern were 
91% and 92%, respectively (27). The high specificity of vas-
cular pattern in differentiating malignant lymph nodes 
from benign ones is due to the low prevalence of periph-
eral vascularity in reactive nodes. Another study report-
ed lower specificity as they categorized inflammatory 
nodes such as tuberculosis in reactive nodes group (16, 
17, 33). The vascular pattern of tuberculosis simulates 
both benign and metastatic patterns and is peripheral 
in 31% of nodes (34). Five metastatic lymph nodes in the 
current study depicted central vascularity. This is pos-
sibly because the vascular pattern of metastatic nodes 
could be central in early stages in response to increased 
local immune reactions (32).
According to our results, RI and PI were significantly 
lower in reactive nodes compared to metastatic nodes. 
This result was in agreement with the results of some 
other studies (35-38). The increase in RI and PI of malig-
nant nodes could be justified by the theory that cell pro-
duction in metastatic nodes could increase the pressure 
on internal structures such as vessels and consequently 
increase their RI and PI (35). On the contrary, Adibelli 
et al. could not find a significant difference in RI and 
PI between these two groups (39). In the present study, 
the most suitable borderline value of RI in differenti-
ating metastatic from reactive lymph nodes was 0.69 
with sensitivity and specificity of 82% and 81%. Ying et 
al. also reported similar cut-points (0.7) with sensitivity 
of 88% and specificity of 78% (5). However, Steinkamp et 
al. reported 0.8 as the optimum borderline value with 
sensitivity of 80% and specificity of 94% (38) Moreover, 
cut-point of 1.35 was calculated as the optimum PI for 
differentiating reactive from metastatic nodes with 
sensitivity and specificity of 82% and 68%, respectively. 
Although, a similar result was reported by Ying et al. 
(cut-point = 1.4) with sensitivity and specificity of 82% 
and 92%, Steinkamp et al. mentioned 1.6 as the cut-point 
with sensitivity of 94% and specificity of 97%, respective-
ly (5, 38).
According to the present study, there was no sig-
nificant difference in average maximum diameters 
between metastatic SCC and reactive nodes. This is in 
concordance with the results of Takeuchi et al. study; 
however, some other studies reported the reverse (24). 
A marked difference in short diameter between the two 
groups was found, which was in concordance with the 
results of some other studies (20, 40-42). Sumi et al. in-
vestigated SCCs of head and neck and reported a signifi-
cant difference in short diameter of benign and meta-
static nodes (40). The cut-off level for short axis in the 
current study was 18.5 mm with 63% sensitivity and 75% 
specificity. Previous studies reported cut-off levels from 
5 to 10 mm and this difference is because we evaluated 
only the largest palpable lymph node in every patient 
(12, 43-45).
According to the previous studies, nodal shape is a valu-
able parameter in differentiating malignant and meta-
static nodes from benign ones (13, 35, 46) Malignant and 
metastatic nodes tend to be round, and benign nodes are 
mostly oval (14, 47, 48). In accordance with recent reports, 
a significant difference in shape was found between 
metastatic and reactive nodes in the present study (P = 
0.023). In the current study, sensitivity and specificity of 
this parameter were 63% and 68%, which is different from 
the results of Mazaher et al. (6) (80.7% and 78.1%, respec-
tively) and Imani Moghaddam et al. (32) (75% and 51%, re-
spectively) studies. Various results can be due to probable 
differences in nodes regions as Ying et al. reported that 
95% of normal submandibular and 59% of normal parotid 
lymph nodes could be round (5).
We did not compute intra-observer reliability in the 
present study and it could be considered in future stud-
ies. In conclusion, gray scale sonography in combina-
tion with Doppler sonography could be a trustworthy 
technique in differentiating metastatic SCC lymph nodes 
from reactive ones. Although, circulation pattern had a 
higher diagnostic accuracy in the present study, combi-
nation of sonographic characteristics could be more ben-
eficial in differentiating metastatic SCC cervical nodes 
from reactive ones.
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